Glycogenic hepatopathy is an under-recognised cause of hepatomegaly and elevated liver transaminases in type 1 diabetes mellitus

N.R. Irani, K. Venugopal, N. Kontorinis, M. Lee, R. Sinniah, Timothy Bates

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Scopus)

    Abstract

    © 2015 Royal Australasian College of Physicians 45 7 July 2015 10.1111/imj.12807 Brief Communications Brief Communication © 2015 Royal Australasian College of Physicians. Glycogenic hepatopathy (GH) is an under-recognised complication of type 1 diabetes mellitus (T1DM) not controlled to target resulting in hepatomegaly and elevated liver transaminases. We report the case of a 19-year-old man with T1DM not controlled to target who presented with abdominal pain, hepatomegaly and deranged liver transaminases. He was subsequently diagnosed with GH on liver biopsy, with the mainstay of treatment being reduction in caloric intake and insulin.
    Original languageEnglish
    Pages (from-to)777-779
    JournalInternal Medicine Journal
    Volume45
    Issue number7
    DOIs
    Publication statusPublished - 2015

    Fingerprint

    Dive into the research topics of 'Glycogenic hepatopathy is an under-recognised cause of hepatomegaly and elevated liver transaminases in type 1 diabetes mellitus'. Together they form a unique fingerprint.

    Cite this